PHILADELPHIA, April 13, 2018 -- Carpenter Technology Corporation (NYSE:CRS) plans to host a conference call and webcast on Thursday, April 26, 2018 at 10:00 a.m. ET to discuss the results of operations for the third quarter of fiscal 2018, ended March 31, 2018. The call and webcast will follow the release of third quarter fiscal 2018 financial results before the market opens on Thursday, April 26, 2018.
Conference Call and Webcast Details
What: Carpenter Technology Third Quarter Fiscal 2018 Conference Call
Date: Thursday, April 26, 2018
Time: 10:00 a.m. Eastern Time
Live Call: +1 412-317-9259
Live and Archived Webcast: www.cartech.com
About Carpenter Technology
Carpenter Technology Corporation is a leading producer and distributor of premium specialty alloys, including titanium alloys, nickel and cobalt based superalloys, stainless steels, alloy steels and tool steels. Carpenter’s high-performance materials and advanced process solutions are an integral part of critical applications used within the aerospace, transportation, medical and energy markets, among other markets. Building on its history of innovation, Carpenter’s powder technology capabilities support a range of next-generation products and manufacturing techniques, including additive manufacturing and 3D Printing. Information about Carpenter can be found at www.cartech.com.
| Media Inquiries: | Investor Inquiries: |
| William J. Rudolph, Jr. | The Plunkett Group |
| +1 610-208-3892 | Brad Edwards |
| [email protected] | +1 212-739-6740 |
| [email protected] |


Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Jefferies Names AMEC Top China Semiconductor Equipment Pick
Street Poller Media and The Boom of the Street Interview Ad Industry
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Google Changes EU Spam Policy Amid Antitrust Scrutiny
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 



